PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2
- 1 June 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 329 (8546) , 1339-1342
- https://doi.org/10.1016/s0140-6736(87)90648-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-Receptors: Interrelationship between 33B3.1, Anti-Tac, and IL2 binding sitesHuman Immunology, 1987
- Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity ConditionsScience, 1986
- OKT3 MONOCLONAL ANTIBODY PLASMA LEVELS DURING THERAPY AND THE SUBSEQUENT DEVELOPMENT OF HOST ANTIBODIES TO OKT3Transplantation, 1986
- Regulation of interleukin 2 receptor expression on a human cytotoxic T lymphocyte clone, synergism between alloantigenic stimulation and interleukin 2.The Journal of Immunology, 1986
- Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody.The Journal of Immunology, 1986
- Anti‐interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody‐receptor interactions in their antagonist effects on interleukin 2‐dependent T cell growthEuropean Journal of Immunology, 1986
- Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.The Journal of Experimental Medicine, 1985
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- SYSTEMATIC TRANSFUSION IN HEMODIALYZED PATIENTS AWAITING GRAFTSTransplantation, 1980
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976